Single and multiple dose evaluation of a novel MetAP2 inhibitor: results of a randomised, double-blind, placebo-controlled clinical trial

被引:0
|
作者
Malloy, J. [1 ]
Zhuang, D. [1 ]
Kim, T. [1 ]
Kim, D. [1 ]
Taylor, K. [1 ]
机构
[1] Zafgen Inc, Boston, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
850
引用
收藏
页码:S394 / S394
页数:1
相关论文
共 50 条
  • [21] ASSESSMENT OF FLUOXETINE IN STROKE RECOVERY (AFFINITY): RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMISED TRIAL
    Hankey, G.
    Hackett, M.
    Almeida, O.
    Flicker, L.
    Mead, G.
    Dennis, M.
    Etherton-Beer, C.
    Ford, A.
    Billot, L.
    Jan, S.
    Anderson, C.
    Gommans, J.
    Lundstrom, E.
    Thang-Nguyen, H.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 4 - 4
  • [22] Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
    Low, Phillip A.
    Robertson, David
    Gilman, Sid
    Kaufmann, Horacio
    Singer, Wolfgang
    Biaggioni, Italo
    Freeman, Roy
    Perlman, Susan
    Hauser, Robert A.
    Cheshire, William
    Lessig, Stephanie
    Vernino, Steven
    Mandrekar, Jay
    Dupont, William D.
    Chelimsky, Thomas
    Galpern, Wendy R.
    LANCET NEUROLOGY, 2014, 13 (03): : 268 - 275
  • [23] Duration of cortisol suppression following a single dose of dexamethasone in healthy volunteers: a randomised double-blind placebo-controlled trial
    Elston, M. S.
    Conaglen, H. M.
    Hughes, C.
    Tamatea, J. A. U.
    Meyer-Rochow, G. Y.
    Conaglen, J. V.
    ANAESTHESIA AND INTENSIVE CARE, 2013, 41 (05) : 596 - 601
  • [24] Randomised clinical trial: high-dose acid suppression for chronic cough - a double-blind, placebo-controlled study
    Shaheen, N. J.
    Crockett, S. D.
    Bright, S. D.
    Madanick, R. D.
    Buckmire, R.
    Couch, M.
    Dellon, E. S.
    Galanko, J. A.
    Sharpless, G.
    Morgan, D. R.
    Spacek, M. B.
    Heidt-Davis, P.
    Henke, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 225 - 234
  • [25] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
    Afshar, H.
    Roohafza, H.
    Mousavi, G.
    Golchin, S.
    Toghianifar, N.
    Sadeghi, M.
    Talaei, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
  • [26] Dalfampiridine improves cognitive impairment in multiple sclerosis (MS): results from a randomised, double-blind, placebo-controlled trial
    De Giglio, Laura
    De Luca, Francesca
    Gurreri, Flavia
    Ferrante, Ilaria
    Prosperini, Luca
    Quartuccio, Maria Esmeralda
    Borriello, Giovanna
    Gasperini, Claudio
    Pozzilli, Carlo
    NEUROLOGY, 2017, 88
  • [27] Topical pentoxifylline for pressure ulcer treatment: a randomised, double-blind , placebo-controlled clinical trial
    Najafi, Elham
    Ahmadi, Motahareh
    Mohammadi, Mostafa
    Beigmohammadi, Mohammad-Taghi
    Heidary, Zinat
    Vatanara, Alireza
    Khalili, Hossein
    JOURNAL OF WOUND CARE, 2018, 27 (08) : 495 - 502
  • [28] Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
    Morice, Alyn H.
    McGarvey, Lorcan
    Pavord, Ian D.
    Higgins, Bernard
    Chung, Kian Fan
    Birring, Surinder S.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (07) : 1864 - 1872
  • [29] A randomized, double-blind, placebo-controlled clinical trial of rifampicin in multiple system atrophy
    Gilman, S.
    Low, P. A.
    Robertson, D.
    Bioggioni, I.
    Freeman, R.
    Kaufmann, H.
    Perlman, S.
    Hauser, R. A.
    Cheshire, W. P.
    Lessig, S. L.
    Vernino, S.
    MOVEMENT DISORDERS, 2012, 27 : S379 - S380
  • [30] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39